Advertisement

Journal of Neural Transmission

, Volume 35, Issue 3, pp 207–215 | Cite as

Glutamate-type hypothalamic-pituitary syndrome in mice treated with aspartate or cysteate in infancy

  • B. Schainker
  • J. W. Olney
Article

Summary

Monosodium L-glutamate (MSG), a neuroexcitatory amino acid is known to destroy hypothalamic (arcuate nucleus) neurons and give rise to subsequent obesity, skeletal stunting and reduced mass of pituitaries, ovaries and testes when administered subcutaneously to infant rodents. Here it is demonstrated that the same hypothalamic lesion and syndrome of neuroendocrine manifestations occurs following treatment of infant mice with either of two other neuroexcitatory amino acids (L-cysteic or L-aspartic acids) which destroy arcuate neurons but not from a structurally related amino acid (DL-α-aminoadipic acid) which lacks neuroexcitatory properties and spares arcuate neurons.

Keywords

Public Health Obesity Aspartate Monosodium Arcuate Nucleus 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Araujo, P. E., andJ. Mayer: Activity increase associated with obesity induced by monosodium glutamate in mice. Am. J. Physiol.225, 764–765 (1973).PubMedGoogle Scholar
  2. Bernardis, L. L.: Prediction of carcass fat, water and lean body mass from Lee's “nutritive ratio” in rats with hypothalamic obesity. Experientia26, 789–790 (1970).PubMedGoogle Scholar
  3. Bernardis, L. L., andB. D. Patterson: Correlation between “Lee Index” and carcass fat content in weanling and adult female rats with hypothalamic lesions. J. Endocr.40, 527–528 (1968).PubMedGoogle Scholar
  4. Björklund, A., andA. Nobin: Fluorescence histochemical and microspectrofluorometric mapping of dopamine and noradrenaline cell groups in the rat diencephalon. Brain Res.51, 193–205 (1973).PubMedGoogle Scholar
  5. Burde, R. M., B. Schainker, andJ. Kayes: Monosodium glutamate: acute effect of oral and subcutaneous administration on the arcuate nucleus of the hypothalamus in mice and rats. Nature233, 58–60 (1971).PubMedGoogle Scholar
  6. Curtis, D. R., andJ. C. Watkins: The excitation and depression of spinal neurons by structurally related amino acids. J. Neurochem.6, 117–141 (1960).PubMedGoogle Scholar
  7. Curtis, D. R., andJ. C. Watkins: Acidic amino acids with strong excitatory actions on mammalian neurons. J. Physiol.166, 1–14 (1963).PubMedGoogle Scholar
  8. Djazayery, A., andD. S. Miller: The use of gold-thioglucose and monosodium glutamate to induce obesity in mice. Proc. Nutr. Soc.32, 30 A (1973).Google Scholar
  9. Everly, J. L.: Light microscopic examination of MSG-induced lesions in brain of fetal and neonatal rats. Anat. Rec.169, 312 (1971).Google Scholar
  10. Fuxe, K., andT. Hökfelt: Catecholamines in the hypothalamus and the pituitary gland. In: Frontiers in Neuroendocrinology (Ganong, W. F., andL. Martini, eds.), pp. 47–96. New York: Oxford University Press. 1969.Google Scholar
  11. Haymaker, W.: Hypothalamo-pituitary neural pathways and the circulatory system of the pituitary. In: The Hypothalamus (Haymaker, W., E. Anderson andW. Nauta, eds.), pp. 219–250. Springfield, Ill.: Charles Thomas. 1969.Google Scholar
  12. Lee, M. O.: Determination of the surface area of the white rat with its application to the expression of metabolic results. Am. J. Physiol.89, 24–31 (1929).Google Scholar
  13. Lemkey-Johnston, N., andW. A. Reynolds: Incidence and extent of brain lesions in mice following ingestion of MSG. Anat. Rec.172, 354 (1972).Google Scholar
  14. Matsuyan, S.: Studies on experimental obesity in mice treated with MSG. Jap. J. Vet. Science32, 206 (1970).Google Scholar
  15. Murakami, U., andM. Inouye: Brain lesions in the mouse fetus caused by maternal administration of monosodium glutamate. Cong. Anomalies11, 171–177 (1971).Google Scholar
  16. Olney, J. W.: Brain lesions, obesity and other disturbances in mice treated with monosodium glutamate. Science164, 719–721 (1969).PubMedGoogle Scholar
  17. Olney, J. W.: Glutamate-induced neuronal necrosis in the infant mouse hypothalamus: An electron microscopic study. J. Neuropath. Exp. Neurol.30, 75–90 (1971).PubMedGoogle Scholar
  18. Olney, J. W., andO.-L. Ho: Brain damage in infant mice following oral intake of glutamate, aspartate or cysteine. Nature227, 609–710 (1970).Google Scholar
  19. Olney, J. W., O.-L. Ho, andV. Rhee: Cytotoxic effects of acidic and sulfur containing amino acids on the infant mouse central nervous system. Exp. Brain Res.14, 61–76 (1971).PubMedGoogle Scholar
  20. Olney, J. W., L. G. Sharpe, andR. D. Feigin: Glutamate-induced brain damage in infant primates. J. Neuropath. Exp. Neurol.31, 464–488 (1972).PubMedGoogle Scholar
  21. Redding, T. W., A. V. Shalley, A. Arimura, andI. Wakaboyashi: Effects of monosodium glutamate on some endocrine functions. Neuroendocrin.8, 245–256 (1971).Google Scholar
  22. Shimizu, K., A. Mizutani, andM. Inouye: Electron microscopic studies on the hypothalamic lesions in the mouse fetus caused by monosodium glutamate. Teratology8, 105 (1973).Google Scholar
  23. Szenthágothai, J., B. Flerkó, B. Mess, andB. Halász: Hypothalamic control of the anterior pituitary, 3rd ed. Budapest: Akadémiai Kiadó. 1968.Google Scholar

Copyright information

© Springer-Verlag 1974

Authors and Affiliations

  • B. Schainker
    • 1
  • J. W. Olney
    • 1
  1. 1.Department of PsychiatryWashington University School of MedicineSt. LouisUSA

Personalised recommendations